ResearcherUniversity of North Carolina at Chapel HillNo recent work listed

Robert W. Corty

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6787-9051; OpenAlex author ID A5034126524. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper

Papers 1

Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients Treated with Gemcitabine for Stage IV Pan… Co-author DOI 10.1634/theoncologist.2019-0570 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hanna Kelly Sanoff · 1 shared paper, 2020 · strength 0.13
- Paper Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients T… DOI 10.1634/theoncologist.2019-0570 ↗
Jennifer Leigh Lund · 1 shared paper, 2020 · strength 0.13
- Paper Antibacterial Use Is Associated with an Increased Risk of Hematologic and Gastrointestinal Adverse Events in Patients T… DOI 10.1634/theoncologist.2019-0570 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.